Company: INV
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001628280-25-052035
Chunk: 44

Company: Innventure, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 1
Chunk 44
---
idiariesNotes to Condensed Consolidated Financial Statements(Unaudited) (in thousands, except share or per share data)

The Company’s June 30, 2025 and March 31, 2025 goodwill impairment testing was performed using the income approach via a discounted cash flow model. The income approach estimates fair value by converting future cash flows to a current amount on the measurement date after taking into consideration marketplace conditions. Assumptions including discount rate and estimated future cash flows had a significant impact to the estimated fair value of the reporting unit. These fair values are Level 3 assets in the fair value hierarchy. In the event there are further adverse changes in the Company’s projected cash flows or further changes in key assumptions, including but not limited to an increase in the discount rate and further decline in the Company’s stock price, the Company may be required to record additional non-cash impairment charges to goodwill. Such non-cash charges could have a material adverse effect on the Company’s condensed consolidated statements of operations and comprehensive income (loss) and condensed consolidated balance sheets in the reporting period of the charge. Other intangible assets, netSeptember 30, 2025December 31, 2024Intangible AssetWeighted-Average Amortization Period Remaining (Years)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying AmountTrade names15.017,800 (1,111)16,689 17,800 $(277)$17,523 Customer relationships2.04,600 (1,532)3,068 4,600 $(382)$4,218 Developed technology 8.3165,100 (18,938)146,162 165,100 $(4,718)$160,382 Other finite-lived intangible assets2.230 (8)22 30 — $30 Total intangible assets$187,530 $(21,589)$165,941 $187,530 $(5,377)$182,153 Amortization expense of $5,404 and $16,212 was recognized for the three and nine months ended September 30, 2025 (Successor), respectively, and is recorded within Cost of sales, General and administrative and Research and development on the condensed consolidated statements of operations and comprehensive income (loss). Estimated future amortization expense is as follows: Amortization Expense2025 (excluding the